|
|
Age : 56 Public asset : 1,526,521 USD Country of residence : Unknown Linked companies :  NovoCure Limited |
| Biography of Asaf Danziger | |
|
| Currently, Asaf Danziger occupies the position of Chief Executive Officer & Director at NovoCure Ltd. and Co-Managing Director at NovoCure GmbH (a subsidiary of NovoCure Ltd.).
In the past Mr. Danziger occupied the position of Chief Executive Officer of Cybro Medical Ltd. and Communications & Electronics Officer at Israel Defense Forces.
He received an undergraduate degree from Ben-Gurion University of the Negev.
|
| Current positions of Asaf Danziger | |
|
| Name | Title |
Since |
NovoCure Limited
(Medical Equipment, Supplies & Distribution) |
Chief Executive Officer & Director |
2012 | | NovoCure GmbH |
Co-Managing Director |
2012 |
|
| Holdings of Asaf Danziger | |
|
| Name | Equities | % | Valuation |
NovoCure Limited (NVCR)
(Medical Equipment, Supplies & Distribution) | 114,776 | 0.11% | 1,526,521 USD |
|
| Asaf Danziger : Personal Network | |
|
|
© 2023 People and Ownership : 
|
| Asaf Danziger : Connections | |
|
|
| Latest news about Asaf Danziger | |
|
| 10/26 | Transcript : NovoCure Limited, Q3 2023 Earnings Call, Oct 26, 2023 | CI |
| 07/27 | Transcript : NovoCure Limited, Q2 2023 Earnings Call, Jul 27, 2023 | CI |
| 05/04 | Transcript : NovoCure Limited, Q1 2023 Earnings Call, May 04, 2023 | CI |
| 02/23 | Transcript : NovoCure Limited, Q4 2022 Earnings Call, Feb 23, 2023 | CI |
| 01/10 | Insider Sell: NovoCure | MT |
| 2022 | Transcript : NovoCure Limited, Q3 2022 Earnings Call, Oct 27, 2022 | CI |
| 2022 | Transcript : NovoCure Limited, Q2 2022 Earnings Call, Jul 28, 2022 | CI |
|
|
Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
